[
  {
    "title": "Merck & Co., Inc. (MRK) Files for Global Approval of Pimicotinib After Positive Phase III TGCT Results",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-files-042935298.html"
  },
  {
    "title": "Merck (NYSE:MRK) Declares US$0.81 Dividend for Q3 2025 Payout",
    "link": "https://finance.yahoo.com/news/merck-nyse-mrk-declares-us-172804041.html"
  },
  {
    "title": "Merck Announces Third-Quarter 2025 Dividend",
    "link": "https://finance.yahoo.com/news/merck-announces-third-quarter-2025-172400938.html"
  },
  {
    "title": "Merus Skyrockets On 'Unprecedented' Cancer Results, Slamming Bicara Therapeutics",
    "link": "https://finance.yahoo.com/m/2c8e50c1-eefe-3582-ab3f-0b4145528a28/merus-skyrockets-on.html"
  },
  {
    "title": "3 Dow Jones Stocks on Our Watchlist",
    "link": "https://finance.yahoo.com/news/3-dow-jones-stocks-watchlist-043239343.html"
  },
  {
    "title": "Merck to Participate in the Bernstein 41st Annual Strategic Decisions Conference",
    "link": "https://finance.yahoo.com/news/merck-participate-bernstein-41st-annual-104500716.html"
  },
  {
    "title": "Merck & Co., Inc. (MRK): A Bull Case Theory",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-bull-152819913.html"
  },
  {
    "title": "Merck (NYSE:MRK) Collaborates With Antengene For Promising Cancer Therapy Evaluation",
    "link": "https://finance.yahoo.com/news/merck-nyse-mrk-collaborates-antengene-174751986.html"
  },
  {
    "title": "PFE vs. MRK: Which Oncology Drug Giant is a Better Buy Now?",
    "link": "https://finance.yahoo.com/news/pfe-vs-mrk-oncology-drug-122900130.html"
  },
  {
    "title": "IDeate-Esophageal01 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Certain Patients with Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma",
    "link": "https://finance.yahoo.com/news/ideate-esophageal01-phase-3-trial-110000591.html"
  },
  {
    "title": "The Top Corporate Board Directors",
    "link": "https://finance.yahoo.com/m/4fe3b211-69b5-312b-b3c4-410f16968161/the-top-corporate-board.html"
  },
  {
    "title": "Merck to Present New Clinical and Outcomes Research Data at The American Thoracic Society’s (ATS) 2025 International Conference Demonstrating Commitment to Advancing Research in Pulmonary Arterial Hypertension",
    "link": "https://finance.yahoo.com/news/merck-present-clinical-outcomes-research-104500895.html"
  },
  {
    "title": "FDA awards cancer drug approvals to AbbVie and MSD",
    "link": "https://finance.yahoo.com/news/fda-awards-cancer-drug-approvals-192618483.html"
  },
  {
    "title": "FDA approves Merck’s belzutifan for pheochromocytoma or paraganglioma",
    "link": "https://finance.yahoo.com/news/fda-approves-merck-belzutifan-pheochromocytoma-160552093.html"
  },
  {
    "title": "Jefferies not seeing significant impact to Merck, Bristol from draft guidance",
    "link": "https://finance.yahoo.com/news/jefferies-not-seeing-significant-impact-144642384.html"
  },
  {
    "title": "Merck Announces Phase 3 KEYNOTE-B96 Trial Met Primary Endpoint of Progression-Free Survival (PFS) in Patients With Platinum-Resistant Recurrent Ovarian Cancer Whose Tumors Expressed PD-L1 and in All Comers",
    "link": "https://finance.yahoo.com/news/merck-announces-phase-3-keynote-104500071.html"
  },
  {
    "title": "The Zacks Analyst Blog Highlights Oracle, IBM, Merck and Earth Science Tech",
    "link": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-oracle-101700486.html"
  },
  {
    "title": "Top Analyst Reports for Oracle, IBM & Merck",
    "link": "https://finance.yahoo.com/news/top-analyst-reports-oracle-ibm-224400474.html"
  },
  {
    "title": "FDA Approves Merck’s WELIREG® (belzutifan) for the Treatment of Adults and Pediatric Patients 12 Years and Older With Locally Advanced, Unresectable, or Metastatic Pheochromocytoma or Paraganglioma (PPGL)",
    "link": "https://finance.yahoo.com/news/fda-approves-merck-welireg-belzutifan-211500267.html"
  },
  {
    "title": "FDA Approves Merck's Kidney Cancer Drug For Rare Type Of Neuroendocrine Tumors",
    "link": "https://finance.yahoo.com/news/fda-approves-mercks-kidney-cancer-191745760.html"
  },
  {
    "title": "Merck (NYSE:MRK) Showcases Broad Cancer Research Portfolio At ASCO Annual Meeting",
    "link": "https://finance.yahoo.com/news/merck-nyse-mrk-showcases-broad-173632693.html"
  },
  {
    "title": "Is Merck & Co. (MRK) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom?",
    "link": "https://finance.yahoo.com/news/merck-co-mrk-best-pharma-210629261.html"
  },
  {
    "title": "Research on Novel Treatment Approaches and Scientific Advances From Merck’s Broad and Differentiated Oncology Portfolio and Pipeline to be Presented at ASCO 2025",
    "link": "https://finance.yahoo.com/news/research-novel-treatment-approaches-scientific-104500648.html"
  },
  {
    "title": "Trump's drug price order is part request, part threat: Analyst",
    "link": "https://finance.yahoo.com/video/trumps-drug-price-order-part-232000676.html"
  },
  {
    "title": "How Trump could go about executing order to slash drug prices",
    "link": "https://finance.yahoo.com/video/trump-could-executing-order-slash-195046744.html"
  },
  {
    "title": "Merck & Co., Inc. (MRK): One of the Worst Blue Chip Stocks to Buy",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-one-190559133.html"
  },
  {
    "title": "Drug wars: Wall Street says big questions remain about impact of Trump's new pricing order",
    "link": "https://finance.yahoo.com/news/drug-wars-wall-street-says-big-questions-remain-about-impact-of-trumps-new-pricing-order-163455794.html"
  },
  {
    "title": "Mag 7 rally, airline & pharmaceutical stocks: Trending Tickers",
    "link": "https://finance.yahoo.com/video/mag-7-rally-airline-pharmaceutical-140147890.html"
  },
  {
    "title": "MRK Q1 Earnings Call: Pipeline Expansion, Tariff Pressures, and Portfolio Diversification",
    "link": "https://finance.yahoo.com/news/mrk-q1-earnings-call-pipeline-094237056.html"
  },
  {
    "title": "Is Merck & Co., Inc. (MRK) the Best Income Stock to Invest in Now?",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-best-081037517.html"
  },
  {
    "title": "Shareholders Will Be Pleased With The Quality of Merck's (NYSE:MRK) Earnings",
    "link": "https://finance.yahoo.com/news/shareholders-pleased-quality-mercks-nyse-111031106.html"
  },
  {
    "title": "Merck Animal Health and State of Kansas Announce $895 Million Investment in Manufacturing and Research & Development Facilities in De Soto",
    "link": "https://finance.yahoo.com/news/merck-animal-health-state-kansas-104500151.html"
  },
  {
    "title": "Is Merck & Co., Inc. (MRK) the Best Dow Stock?",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-best-205508834.html"
  },
  {
    "title": "Merck (NYSE:MRK) Launches Next-Gen Digital Ecosystem for Growth Disorders with Dawn Health",
    "link": "https://finance.yahoo.com/news/merck-nyse-mrk-launches-next-175449851.html"
  },
  {
    "title": "Merck & Co., Inc. (MRK): Among Billionaire Mario Gabelli’s Large-Cap Stock Picks with Huge Upside Potential",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-among-122532131.html"
  },
  {
    "title": "Merck to Participate in the Bank of America 2025 Global Healthcare Conference",
    "link": "https://finance.yahoo.com/news/merck-participate-bank-america-2025-104500127.html"
  },
  {
    "title": "Why A Short Strangle Trade Might Be Best For Volatile Stocks Like Merck",
    "link": "https://finance.yahoo.com/m/627e5b40-a9f8-3563-a842-3ee5f16a3ad3/why-a-short-strangle-trade.html"
  },
  {
    "title": "Is Merck & Co., Inc. (MRK) The Most Profitable Cheap Stock to Buy Now?",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-most-150004645.html"
  },
  {
    "title": "Merck & Co., Inc. (MRK): Jim Cramer Agrees – “Merck’s A Good Company”",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-jim-212340697.html"
  },
  {
    "title": "Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know",
    "link": "https://finance.yahoo.com/news/investors-heavily-search-merck-co-130015936.html"
  },
  {
    "title": "Top Dividend Stocks To Consider In May 2025",
    "link": "https://finance.yahoo.com/news/top-dividend-stocks-consider-may-113134855.html"
  },
  {
    "title": "Is Merck & Co. Inc. (MRK) the Best Dow Stock for the Next 12 Months?",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-best-182554398.html"
  },
  {
    "title": "Merck & Co., Inc. (MRK): Among Billionaire Cliff Asness’ Stock Picks with Huge Upside Potential",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-among-151814822.html"
  },
  {
    "title": "Construction begins on MSD’s $1bn biologics centre in Delaware, US",
    "link": "https://finance.yahoo.com/news/construction-begins-msd-1bn-biologics-094122603.html"
  },
  {
    "title": "How To Put $100 In Your Retirement Fund Each Month With Merck Stock",
    "link": "https://finance.yahoo.com/news/put-100-retirement-fund-month-161126538.html"
  },
  {
    "title": "Pfizer offers 'longer-term' opportunity amid tariff uncertainty",
    "link": "https://finance.yahoo.com/video/pfizer-offers-longer-term-opportunity-143115195.html"
  },
  {
    "title": "Is Merck & Co., Inc. (MRK) the Worst-Performing Blue Chip Stock So Far in 2025?",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-worst-142703247.html"
  },
  {
    "title": "Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, Delaware",
    "link": "https://finance.yahoo.com/news/merck-breaks-ground-1-billion-104500898.html"
  },
  {
    "title": "Merck to Spend $1 Billion on New Factory to Make U.S. Supplies of Blockbuster Drug",
    "link": "https://finance.yahoo.com/m/7dd6aceb-3f28-35d1-93cf-6b228aa31447/merck-to-spend-1-billion-on.html"
  },
  {
    "title": "Merck (NYSE:MRK) Presents Promising KEYTRUDA Trial Data at AACR 2025 Meeting",
    "link": "https://finance.yahoo.com/news/merck-nyse-mrk-presents-promising-174256994.html"
  },
  {
    "title": "Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion",
    "link": "https://finance.yahoo.com/news/merck-germany-buys-us-cancer-161758011.html"
  },
  {
    "title": "Temu, Tesla prices, Merck KGaA deal: Trending Tickers",
    "link": "https://finance.yahoo.com/video/temu-tesla-prices-merck-kgaa-143538185.html"
  },
  {
    "title": "Is Merck & Co., Inc. (MRK) the Most Profitable Blue Chip Stock to Buy Now?",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-most-131935771.html"
  },
  {
    "title": "Should You Buy, Sell or Hold MRK Stock After Q1 Earnings Beat?",
    "link": "https://finance.yahoo.com/news/buy-sell-hold-mrk-stock-114800078.html"
  },
  {
    "title": "Merck & Co., Inc. (MRK): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-among-190803126.html"
  },
  {
    "title": "KEYTRUDA® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma",
    "link": "https://finance.yahoo.com/news/keytruda-pembrolizumab-perioperative-treatment-standard-160000135.html"
  },
  {
    "title": "Wall Street’s New Tariff Safe Haven: High-Tax Biotech Stocks",
    "link": "https://finance.yahoo.com/m/54caf1db-e1d5-3dfe-b9ff-638d5851edfa/wall-street%E2%80%99s-new-tariff-safe.html"
  },
  {
    "title": "Akeso survival data for ivonescimab misses expectations, STAT says",
    "link": "https://finance.yahoo.com/news/akeso-survival-data-ivonescimab-misses-165017764.html"
  },
  {
    "title": "Merck First Quarter 2025 Earnings: Beats Expectations",
    "link": "https://finance.yahoo.com/news/merck-first-quarter-2025-earnings-130049639.html"
  },
  {
    "title": "Company News for Apr 25, 2025",
    "link": "https://finance.yahoo.com/news/company-news-apr-25-2025-132500748.html"
  },
  {
    "title": "Stocks to Watch Recap: Alphabet, Intel, P&G, Merck",
    "link": "https://finance.yahoo.com/m/b43a1dbf-f797-39e8-a512-04fe9c519fcc/stocks-to-watch-recap-.html"
  },
  {
    "title": "Merck Stock Reverses, Though Gardasil 'Woes' Continue In China, Japan",
    "link": "https://finance.yahoo.com/m/08e7c6e4-d3b9-3da2-9c0f-bc97fc9cf269/merck-stock-reverses-though.html"
  },
  {
    "title": "Merck Q1 Earnings & Sales Beat Estimates, '25 EPS Outlook Cut",
    "link": "https://finance.yahoo.com/news/merck-q1-earnings-sales-beat-182000451.html"
  },
  {
    "title": "Merck (NYSE:MRK) Faces Patent Lawsuit As Earnings Grow US$317 Million In Q1",
    "link": "https://finance.yahoo.com/news/merck-nyse-mrk-faces-patent-180744722.html"
  },
  {
    "title": "Merck warns of big tariff hit, Hasbro soars, Comcast sinks",
    "link": "https://finance.yahoo.com/video/merck-warns-big-tariff-hit-172053404.html"
  },
  {
    "title": "Merck Cuts 2025 Outlook on Tariffs, Charges",
    "link": "https://finance.yahoo.com/m/bf2553e4-1163-3458-8d6a-16031da27ed8/merck-cuts-2025-outlook-on.html"
  },
  {
    "title": "Merck, Nokia, Texas Instruments: Trending Tickers",
    "link": "https://finance.yahoo.com/video/merck-nokia-texas-instruments-trending-133734260.html"
  },
  {
    "title": "Merck takes $200M tariff hit, trimming its gross profits",
    "link": "https://finance.yahoo.com/news/merck-takes-200m-tariff-hit-114300618.html"
  },
  {
    "title": "Merck’s (NYSE:MRK) Q1 Sales Beat Estimates",
    "link": "https://finance.yahoo.com/news/merck-nyse-mrk-q1-sales-110727855.html"
  },
  {
    "title": "Merck: Q1 Earnings Snapshot",
    "link": "https://finance.yahoo.com/news/merck-q1-earnings-snapshot-104017370.html"
  },
  {
    "title": "Merck Announces First-Quarter 2025 Financial Results",
    "link": "https://finance.yahoo.com/news/merck-announces-first-quarter-2025-103000298.html"
  },
  {
    "title": "Alphabet earnings, Fed comments, Nintendo Switch 2: What to Watch",
    "link": "https://finance.yahoo.com/video/alphabet-earnings-fed-comments-nintendo-230000088.html"
  },
  {
    "title": "BioNTech Surges On Summit's Coattails. But Can They Take On Merck?",
    "link": "https://finance.yahoo.com/m/a6583d72-b7a0-347a-829e-9cdb842158e1/biontech-surges-on-summit-s.html"
  },
  {
    "title": "Why vaccine makers aren't worried about Trump administration cuts",
    "link": "https://finance.yahoo.com/news/why-vaccine-makers-arent-worried-about-trump-administration-cuts-185027024.html"
  },
  {
    "title": "Is Merck & Co., Inc. (MRK) the Best Stock To Buy According to Marjorie Taylor Greene?",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-best-170817705.html"
  },
  {
    "title": "Merck (MRK) Reports Q1: Everything You Need To Know Ahead Of Earnings",
    "link": "https://finance.yahoo.com/news/merck-mrk-reports-q1-everything-120232660.html"
  },
  {
    "title": "Merck & Co., Inc. (MRK): Among Prem Watsa’s Stock Picks With Highest Potential",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-among-010136693.html"
  },
  {
    "title": "Merck Q1 Earnings Coming Up: Should You Buy the Stock Now?",
    "link": "https://finance.yahoo.com/news/merck-q1-earnings-coming-buy-113200343.html"
  },
  {
    "title": "Health Canada Approves KEYTRUDA® Plus Pemetrexed and Platinum Chemotherapy as First-Line Treatment for Adult Patients with Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma (MPM)",
    "link": "https://finance.yahoo.com/news/health-canada-approves-keytruda-plus-110000111.html"
  },
  {
    "title": "Merck & Co., Inc. (MRK): Among Value Stocks in Ken Fisher’s Portfolio",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-among-154436860.html"
  },
  {
    "title": "Why Merck, Black Hills, And Virtus Investment Partners Are Winners For Passive Income",
    "link": "https://finance.yahoo.com/news/why-merck-black-hills-virtus-010012257.html"
  },
  {
    "title": "Is Merck & Co., Inc. (MRK) the Best Large-Cap Value Stock to Buy as the Recession Hits?",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-best-140339758.html"
  },
  {
    "title": "Stocks to watch this week: Tesla, Alphabet, Intel, Boeing and Unilever",
    "link": "https://finance.yahoo.com/news/tesla-alphabet-intel-boeing-unilever-stocks-to-watch-050026597.html"
  },
  {
    "title": "Is Merck & Co., Inc. (MRK) The Dirt Cheap Stock To Invest In Now?",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-dirt-171334421.html"
  },
  {
    "title": "Merck (MRK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release",
    "link": "https://finance.yahoo.com/news/merck-mrk-earnings-expected-grow-140101939.html"
  },
  {
    "title": "Merck & Co., Inc. (MRK): Among the Innovative Healthcare Stocks to Watch in 2025",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-among-135553479.html"
  },
  {
    "title": "Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock",
    "link": "https://finance.yahoo.com/news/know-beyond-why-merck-co-130014205.html"
  },
  {
    "title": "Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers",
    "link": "https://finance.yahoo.com/news/pharmaceuticals-stocks-q4-review-jazz-090614474.html"
  },
  {
    "title": "Merck (NYSE:MRK) Secures Global Rights To Cyprumed's Oral Peptide Delivery Technology",
    "link": "https://finance.yahoo.com/news/merck-nyse-mrk-secures-global-174624411.html"
  },
  {
    "title": "Is Merck & Co., Inc. (MRK) the Best Pharma Stock to Buy for Long Term Growth?",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-best-165618385.html"
  },
  {
    "title": "Is Merck & Co Inc. (NYSE:MRK) the Most Undervalued Quality Stock to Buy Now?",
    "link": "https://finance.yahoo.com/news/merck-co-inc-nyse-mrk-135315697.html"
  },
  {
    "title": "Merck & Co. Inc. (MRK): Among the High Growth Forever Dividend Stocks to Invest In",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-among-135935385.html"
  },
  {
    "title": "ABBV vs. MRK: Which Drug Giant is a Better Buy Now?",
    "link": "https://finance.yahoo.com/news/abbv-vs-mrk-drug-giant-143700084.html"
  },
  {
    "title": "Is Merck & Co. (NYSE:MRK) a Cheap NYSE Stock to Invest in According to Hedge Funds?",
    "link": "https://finance.yahoo.com/news/merck-co-nyse-mrk-cheap-142910051.html"
  },
  {
    "title": "Is Merck & Co., Inc. (MRK) the Best Medical Stock to Buy According to Billionaires?",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-best-215759150.html"
  },
  {
    "title": "Jim Cramer on Merck (MRK): Stay The Course… It’s Been a Real Tough One",
    "link": "https://finance.yahoo.com/news/jim-cramer-merck-mrk-stay-163345390.html"
  },
  {
    "title": "Merck (NYSE:MRK) Faces Multiple Shareholder Proposals Ahead Of Annual Meeting",
    "link": "https://finance.yahoo.com/news/merck-nyse-mrk-faces-multiple-172317255.html"
  },
  {
    "title": "S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash",
    "link": "https://finance.yahoo.com/m/5788e167-ba2e-3f2d-8e9e-4bfb72e0e2c1/s-p-dow-jones-pharma-names.html"
  },
  {
    "title": "Apple, Alibaba, drugmaker stocks: Trending Tickers",
    "link": "https://finance.yahoo.com/video/apple-alibaba-drugmaker-stocks-trending-144322260.html"
  },
  {
    "title": "Trump says pharmaceutical tariffs may be coming: What to know",
    "link": "https://finance.yahoo.com/video/trump-says-pharmaceutical-tariffs-may-141157823.html"
  },
  {
    "title": "Dow Jones, S&P 500 Pharma Names Recover After Trump Backs Off His Tariffs Plan",
    "link": "https://finance.yahoo.com/m/be7d1b24-7c1e-38ff-91b2-281ea7807568/dow-jones-s-p-500-pharma.html"
  },
  {
    "title": "Trump Tariff News: New Tariffs Begin, China Retaliates; Treasury Yields Spike While Delta, Walmart Pull Guidance",
    "link": "https://finance.yahoo.com/m/a3b4073e-cf6b-3c9f-8915-5acaa3968de0/trump-tariff-news-new.html"
  },
  {
    "title": "Merck & Co., Inc. (MRK): Among Defensive Stocks Billionaire Ken Fisher is Betting On",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-among-221507847.html"
  },
  {
    "title": "Walgreens, CVS, & US drugmakers make big moves: What to know",
    "link": "https://finance.yahoo.com/video/walgreens-cvs-us-drugmakers-big-140318681.html"
  },
  {
    "title": "Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment",
    "link": "https://finance.yahoo.com/news/q4-earnings-roundup-organon-nyse-090718154.html"
  },
  {
    "title": "2 Reasons to Like MRK (and 1 Not So Much)",
    "link": "https://finance.yahoo.com/news/2-reasons-mrk-1-not-091045372.html"
  },
  {
    "title": "Pharma Stocks Aren't in the Clear, Despite Tariff Exemption—Heard on the Street",
    "link": "https://finance.yahoo.com/m/4d202ae2-292d-33fc-b5df-f9468db0055c/pharma-stocks-aren-t-in-the.html"
  },
  {
    "title": "3 Dividend Stocks To Consider With Yields Up To 4.2%",
    "link": "https://finance.yahoo.com/news/3-dividend-stocks-consider-yields-170138184.html"
  },
  {
    "title": "Wall Street Analysts Think Merck (MRK) Is a Good Investment: Is It?",
    "link": "https://finance.yahoo.com/news/wall-street-analysts-think-merck-133010906.html"
  },
  {
    "title": "The Zacks Analyst Blog Highlights Amazon.com, Oracle and Merck",
    "link": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-amazon-131400616.html"
  },
  {
    "title": "Top Analyst Reports for Amazon, Oracle & Merck",
    "link": "https://finance.yahoo.com/news/top-analyst-reports-amazon-oracle-205900596.html"
  },
  {
    "title": "Merck to Hold First-Quarter 2025 Sales and Earnings Conference Call April 24",
    "link": "https://finance.yahoo.com/news/merck-hold-first-quarter-2025-104500687.html"
  },
  {
    "title": "Does AstraZeneca Have 'One Pill To Rule Them All' In Cholesterol?",
    "link": "https://finance.yahoo.com/m/88800b5c-ff5c-3c4f-bae4-af0c19fd8b46/does-astrazeneca-have-one.html"
  },
  {
    "title": "Merck (NYSE:MRK) Reports Strong Phase 3 Results For WINREVAIR In PAH Treatment",
    "link": "https://finance.yahoo.com/news/merck-nyse-mrk-reports-strong-173141485.html"
  },
  {
    "title": "WINREVAIR™ (sotatercept-csrk) Reduced the Risk of a Composite of All-Cause Death, Lung Transplantation and Hospitalization for Pulmonary Arterial Hypertension (PAH) by 76% Compared to Placebo in the Phase 3 ZENITH Trial",
    "link": "https://finance.yahoo.com/news/winrevair-sotatercept-csrk-reduced-risk-140000714.html"
  },
  {
    "title": "Why Merck & Co. Inc. (MRK) Went Up On Friday?",
    "link": "https://finance.yahoo.com/news/why-merck-co-inc-mrk-023140399.html"
  },
  {
    "title": "China Expansion Helps Fuel This AI-Powered Cloud Stock In Rough Market",
    "link": "https://finance.yahoo.com/m/fd7b1a1d-d67e-3eeb-93e9-0fa93dd300fa/china-expansion-helps-fuel.html"
  },
  {
    "title": "FDA Accepts Merck's Filing for Subcutaneous Version of Keytruda",
    "link": "https://finance.yahoo.com/news/fda-accepts-mercks-filing-subcutaneous-152000184.html"
  },
  {
    "title": "Is Merck & Co. (MRK) the Low Volatility Stock to Buy According to Billionaire Ken Fisher?",
    "link": "https://finance.yahoo.com/news/merck-co-mrk-low-volatility-213637264.html"
  },
  {
    "title": "Merck's Biggest Moneymaker Could Get Even Bigger. But Will It Help Downtrodden Shares?",
    "link": "https://finance.yahoo.com/m/7fa62fa5-4885-32e4-a151-464172a9773f/merck-s-biggest-moneymaker.html"
  },
  {
    "title": "Merck releases positive data for blockbuster cancer drug",
    "link": "https://finance.yahoo.com/video/merck-releases-positive-data-blockbuster-201400957.html"
  },
  {
    "title": "Merck’s Investigational Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Demonstrates Noninferior Pharmacokinetics Compared to Intravenous (IV) KEYTRUDA® (pembrolizumab) in Pivotal 3475A-D77 Trial",
    "link": "https://finance.yahoo.com/news/merck-investigational-subcutaneous-pembrolizumab-berahyaluronidase-150100421.html"
  },
  {
    "title": "Positive phase III data gives Merck potential boost for blockbuster Keytruda in injection form",
    "link": "https://finance.yahoo.com/news/positive-phase-iii-data-gives-merck-potential-boost-for-blockbuster-keytruda-in-injection-form-150009481.html"
  },
  {
    "title": "Here is Why Jim Cramer Is Bullish About Merck (MRK)",
    "link": "https://finance.yahoo.com/news/why-jim-cramer-bullish-merck-014113098.html"
  },
  {
    "title": "Is Merck & Co., Inc. (MRK) the Best Consistent Dividend Stock to Buy?",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-best-220946172.html"
  },
  {
    "title": "Jim Cramer on Merck (MRK): “I Like It at This Level – But I Like Bristol-Myers Even More!”",
    "link": "https://finance.yahoo.com/news/jim-cramer-merck-mrk-level-174513723.html"
  },
  {
    "title": "Merck (NYSE:MRK) Gains EC Approval For CAPVAXIVE® Amid Recent 7% Share Price Dip",
    "link": "https://finance.yahoo.com/news/merck-nyse-mrk-gains-ec-173210476.html"
  },
  {
    "title": "European Commission (EC) Approves Merck’s CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults",
    "link": "https://finance.yahoo.com/news/european-commission-ec-approves-merck-104500234.html"
  },
  {
    "title": "Why Merck & Co. Inc. (MRK) Performed Worst On Tuesday?",
    "link": "https://finance.yahoo.com/news/why-merck-co-inc-mrk-091950707.html"
  },
  {
    "title": "Is Merck & Co. Inc. (MRK) The Best Defensive Stock Amid Market Volatility?",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-best-214851022.html"
  },
  {
    "title": "Merck Bets $2B on China's Hengrui for Next Big Heart Drug",
    "link": "https://finance.yahoo.com/news/merck-bets-2b-chinas-hengrui-190053022.html"
  },
  {
    "title": "Trump tariffs drive pharma manufacturing to US but risk inflation and disruption",
    "link": "https://finance.yahoo.com/news/trump-tariffs-drive-pharma-manufacturing-120317644.html"
  },
  {
    "title": "Is Weakness In Merck & Co., Inc. (NYSE:MRK) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?",
    "link": "https://finance.yahoo.com/news/weakness-merck-co-inc-nyse-120011701.html"
  },
  {
    "title": "Merck bets $200M on a new type of heart pill",
    "link": "https://finance.yahoo.com/news/merck-bets-200m-type-heart-115900444.html"
  },
  {
    "title": "Merck Enters Exclusive License Agreement for HRS-5346, an Investigational Oral Lipoprotein(a) Inhibitor, for Cardiovascular Disease from Jiangsu Hengrui Pharmaceuticals Co., Ltd.",
    "link": "https://finance.yahoo.com/news/merck-enters-exclusive-license-agreement-104500174.html"
  },
  {
    "title": "Is Merck & Co. (MRK) The Best Healthcare Dividend Stock to Invest in?",
    "link": "https://finance.yahoo.com/news/merck-co-mrk-best-healthcare-131026080.html"
  },
  {
    "title": "1 Value Stock with Solid Fundamentals and 2 to Turn Down",
    "link": "https://finance.yahoo.com/news/1-value-stock-solid-fundamentals-130202189.html"
  },
  {
    "title": "Merck & Co. (MRK): Among Stocks Insiders Were Piling Into Recently",
    "link": "https://finance.yahoo.com/news/merck-co-mrk-among-stocks-203525623.html"
  },
  {
    "title": "3 of Goldman Sachs' best investing tips for currently volatile markets",
    "link": "https://finance.yahoo.com/news/3-of-goldman-sachs-best-investing-tips-for-currently-volatile-markets-133052214.html"
  },
  {
    "title": "Merck (NYSE:MRK) Unveils New Data On Cardiovascular Advances At ACC.25 Annual Conference",
    "link": "https://finance.yahoo.com/news/merck-nyse-mrk-unveils-data-173201784.html"
  },
  {
    "title": "Merck & Co., Inc. (MRK): Among Incredibly Cheap Dividend Stock to Buy Now",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-among-152627393.html"
  },
  {
    "title": "Why Merck & Co. (MRK) Is Among the Most Undervalued Biotech Stocks to Invest In",
    "link": "https://finance.yahoo.com/news/why-merck-co-mrk-among-144539340.html"
  },
  {
    "title": "Merck Loses Almost $52B in 6 Months: How to Play MRK Stock",
    "link": "https://finance.yahoo.com/news/merck-loses-almost-52b-6-141100377.html"
  },
  {
    "title": "Actinium Pharmaceuticals launches clinical trial for Actimab-A in combination",
    "link": "https://finance.yahoo.com/news/actinium-pharmaceuticals-launches-clinical-trial-121132642.html"
  },
  {
    "title": "Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy",
    "link": "https://finance.yahoo.com/news/health-canada-approves-keytruda-treatment-110000080.html"
  },
  {
    "title": "Merck Data at ACC.25 Highlight Innovative Advancements and Commitment to Improving Outcomes for People Living with Cardiovascular Disease",
    "link": "https://finance.yahoo.com/news/merck-data-acc-25-highlight-104500619.html"
  },
  {
    "title": "Is Merck & Co Inc. (NYSE:MRK) the Most Undervalued S&P 500 Stock to Buy Now?",
    "link": "https://finance.yahoo.com/news/merck-co-inc-nyse-mrk-124656795.html"
  },
  {
    "title": "Is Merck & Co Inc. (NYSE:MRK) the Most Profitable Value Stock to Buy Now?",
    "link": "https://finance.yahoo.com/news/merck-co-inc-nyse-mrk-193228677.html"
  },
  {
    "title": "Merck & Co., Inc. (MRK): Among Top Dividend Contenders List",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-among-170632968.html"
  },
  {
    "title": "MSD to push for approval of HIV combo after Phase III success",
    "link": "https://finance.yahoo.com/news/msd-push-approval-hiv-combo-124947277.html"
  },
  {
    "title": "Merck & Co., Inc. (NYSE:MRK) Looks Interesting, And It's About To Pay A Dividend",
    "link": "https://finance.yahoo.com/news/merck-co-inc-nyse-mrk-110805229.html"
  },
  {
    "title": "Why Merck & Co., Inc. (MRK) is the Best Pharma Stock to Buy According to Hedge Funds",
    "link": "https://finance.yahoo.com/news/why-merck-co-inc-mrk-183220672.html"
  },
  {
    "title": "Merck Plans Regulatory Submission For Two-Drug Regime For HIV Infection By Mid-2025",
    "link": "https://finance.yahoo.com/news/merck-plans-regulatory-submission-two-173037785.html"
  },
  {
    "title": "Merck Announces Positive Data from Phase 3 Trials that Show the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) Maintained HIV-1 Viral Suppression at Week 48",
    "link": "https://finance.yahoo.com/news/merck-announces-positive-data-phase-152600652.html"
  },
  {
    "title": "Merck & Co., Inc. (MRK): Among Dobermans of the Dow to Buy",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-among-141115775.html"
  },
  {
    "title": "Merck (NYSE:MRK) Unveils US$1 Billion Durham Facility For Advanced Vaccine Manufacturing Expansion",
    "link": "https://finance.yahoo.com/news/merck-nyse-mrk-unveils-us-174715502.html"
  },
  {
    "title": "Zacks Investment Ideas feature highlights: Molson Coors, Merck & Co. and Deutsche Telekom",
    "link": "https://finance.yahoo.com/news/zacks-investment-ideas-feature-highlights-135300009.html"
  },
  {
    "title": "Merck Unveils New Facility to Increase Vaccine Production Capacity",
    "link": "https://finance.yahoo.com/news/merck-unveils-facility-increase-vaccine-104500733.html"
  },
  {
    "title": "Merck & Co. (MRK): Hedge Funds Are Bullish On This Oversold Blue Chip Stock Now",
    "link": "https://finance.yahoo.com/news/merck-co-mrk-hedge-funds-082221064.html"
  },
  {
    "title": "Wall Street Analysts Think This Medical Dividend Stock Could Have Massive 82% Upside",
    "link": "https://finance.yahoo.com/news/wall-street-analysts-think-medical-020042123.html"
  },
  {
    "title": "Merck & Co. (MRK): One of the Most Undervalued US Stocks to Buy According to Hedge Funds",
    "link": "https://finance.yahoo.com/news/merck-co-mrk-one-most-204051947.html"
  },
  {
    "title": "Safe Haven Stocks: 3 Top Picks for Navigating Volatility",
    "link": "https://finance.yahoo.com/news/safe-haven-stocks-3-top-191900390.html"
  },
  {
    "title": "Stock market sell-off: Why these stocks are in the green amid the pain",
    "link": "https://finance.yahoo.com/news/stock-market-sell-off-why-these-stocks-are-in-the-green-amid-the-pain-181712451.html"
  },
  {
    "title": "Is Merck & Co., Inc. (MRK) the Most Undervalued High Quality Stock to Buy According to Analysts?",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-most-204524798.html"
  },
  {
    "title": "Merck & Co., Inc. (MRK) Among The Best Cheap Dividend Stock To Buy Right Now",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-among-205258811.html"
  },
  {
    "title": "Merck & Co. (MRK): Among the Best Undervalued Stocks to Invest In Now",
    "link": "https://finance.yahoo.com/news/merck-co-mrk-among-best-193205645.html"
  },
  {
    "title": "Merck (MRK) Up 3.9% Since Last Earnings Report: Can It Continue?",
    "link": "https://finance.yahoo.com/news/merck-mrk-3-9-since-163110268.html"
  },
  {
    "title": "Merck & Co. (MRK): An Undervalued Wide Moat Stock to Buy According to Analysts",
    "link": "https://finance.yahoo.com/news/merck-co-mrk-undervalued-wide-205726308.html"
  },
  {
    "title": "New Version of Merck’s Blockbuster Cancer Drug Threatened by Patent Battle",
    "link": "https://finance.yahoo.com/m/2237d2dd-bfcc-3a9d-9b9d-7cbeeee05ce6/new-version-of-merck%E2%80%99s.html"
  },
  {
    "title": "Is Merck & Co., Inc. (MRK) The Best Immunology Stock To Buy Now?",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-best-110406664.html"
  },
  {
    "title": "Merck & Co. (MRK): One of the Best Psychedelic Stocks to Buy in 2025",
    "link": "https://finance.yahoo.com/news/merck-co-mrk-one-best-205948152.html"
  },
  {
    "title": "Is Merck & Co., Inc. (MRK) the Best Dividend Stock to Buy According to Billionaires?",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-best-164135728.html"
  },
  {
    "title": "Merck's (NYSE:MRK) Earnings May Just Be The Starting Point",
    "link": "https://finance.yahoo.com/news/mercks-nyse-mrk-earnings-may-103345317.html"
  },
  {
    "title": "Merck & Co., Inc. (MRK): Among the Best Affordable Dividend Stocks to Buy According to Hedge Funds",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-among-190816166.html"
  },
  {
    "title": "Is Merck & Co., Inc. (MRK) the Best Magic Formula Stock for 2025?",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-best-173536228.html"
  },
  {
    "title": "Merck Slips 8% in a Month: Should You Buy, Hold or Sell the Stock?",
    "link": "https://finance.yahoo.com/news/merck-slips-8-month-buy-134500549.html"
  },
  {
    "title": "Earnings Update: Merck & Co., Inc. (NYSE:MRK) Just Reported Its Full-Year Results And Analysts Are Updating Their Forecasts",
    "link": "https://finance.yahoo.com/news/earnings-merck-co-inc-nyse-122039891.html"
  },
  {
    "title": "Merck & Co., Inc. (MRK): One of the Best Vaccine Stocks to Buy According to Hedge Funds",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-one-133700022.html"
  },
  {
    "title": "3 Leading Dividend Stocks To Consider With Up To 5.6% Yield",
    "link": "https://finance.yahoo.com/news/3-leading-dividend-stocks-consider-110146873.html"
  },
  {
    "title": "Is Merck & Co., Inc. (MRK) the Best Retirement Stock to Buy According to Hedge Funds?",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-best-205010080.html"
  },
  {
    "title": "Why Polaris, Merck, And Skyworks Solutions Are Winners For Passive Income",
    "link": "https://finance.yahoo.com/news/why-polaris-merck-skyworks-solutions-151514292.html"
  },
  {
    "title": "Merck & Co., Inc. (MRK): Among Bourgeon Capital’s Top Stock Picks",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-among-144539188.html"
  },
  {
    "title": "Despite delivering investors losses of 27% over the past 1 year, Merck (NYSE:MRK) has been growing its earnings",
    "link": "https://finance.yahoo.com/news/despite-delivering-investors-losses-27-140013263.html"
  },
  {
    "title": "Cancer vaccines have stumbled, but the approach is gaining new steam",
    "link": "https://finance.yahoo.com/news/cancer-vaccines-stumbled-approach-gaining-080000675.html"
  },
  {
    "title": "Eikon raises $351M in one of the year’s largest biotech venture rounds",
    "link": "https://finance.yahoo.com/news/eikon-raises-351m-one-largest-070000073.html"
  },
  {
    "title": "Jim Cramer Says Merck & Co., Inc. (MRK) Is ‘Maybe The Ultimate Laggard’",
    "link": "https://finance.yahoo.com/news/jim-cramer-says-merck-co-163549716.html"
  },
  {
    "title": "Wall Street Analysts See Merck (MRK) as a Buy: Should You Invest?",
    "link": "https://finance.yahoo.com/news/wall-street-analysts-see-merck-143012293.html"
  },
  {
    "title": "FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma",
    "link": "https://finance.yahoo.com/news/fda-grants-priority-review-merck-114500312.html"
  },
  {
    "title": "5 Stocks in the Dow ETF That Survived the Worst Week Since October",
    "link": "https://finance.yahoo.com/news/5-stocks-dow-etf-survived-143000372.html"
  },
  {
    "title": "Merck to Participate in the TD Cowen 45th Annual Health Care Conference",
    "link": "https://finance.yahoo.com/news/merck-participate-td-cowen-45th-114500988.html"
  },
  {
    "title": "Merck & Co., Inc. (MRK): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-among-140830114.html"
  },
  {
    "title": "Merck & Co., Inc. (MRK): Among the Most Expensive Stocks Insiders Are Buying Recently",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-among-165528377.html"
  },
  {
    "title": "2 Healthcare Stocks with Big Upside and 1 to Skip",
    "link": "https://finance.yahoo.com/news/2-healthcare-stocks-big-upside-130059575.html"
  },
  {
    "title": "Merck & Co., Inc. (MRK): Among the Cheap High Dividend Stocks to Invest In Now",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-among-205504348.html"
  },
  {
    "title": "Is Merck & Co., Inc. (MRK) the Best Very Cheap Stock To Buy Right Now?",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-best-182759731.html"
  },
  {
    "title": "Europe Approves Merck's Cancer Drug For Two Indications",
    "link": "https://finance.yahoo.com/news/europe-approves-mercks-cancer-drug-170040277.html"
  },
  {
    "title": "Merck & Co., Inc. (MRK): Among the Best Drug Stocks to Buy Now",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-among-115644263.html"
  },
  {
    "title": "WELIREG® (belzutifan) Receives First European Commission Approval for Two Indications",
    "link": "https://finance.yahoo.com/news/welireg-belzutifan-receives-first-european-114500122.html"
  },
  {
    "title": "Is Merck & Co., Inc. (MRK) the Most Oversold S&P 500 Stock in 2024?",
    "link": "https://finance.yahoo.com/news/merck-co-inc-mrk-most-015726175.html"
  },
  {
    "title": "Jim Cramer Comments on Merck & Co., Inc. (MRK) and Its China Woes",
    "link": "https://finance.yahoo.com/news/jim-cramer-comments-merck-co-183022690.html"
  }
]